Ling Zhi-8 inhibits EGFR signaling pathways-mediated EMT in lung cancer cells
碩士 === 國立陽明大學 === 醫學生物技術暨檢驗學系 === 100 === Ling Zhi-8 (LZ-8) is a human immune-modulatory protein from Ganoderma lucidum. Our recent study demonstrated that LZ-8 effectively can prevent lung cancer cell proliferation; however, the mechanism of recombinant LZ-8 (rLZ-8) exhibits anti-metastasis propert...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | en_US |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/59224975227450337450 |
id |
ndltd-TW-100YM005604006 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-100YM0056040062015-10-13T21:22:39Z http://ndltd.ncl.edu.tw/handle/59224975227450337450 Ling Zhi-8 inhibits EGFR signaling pathways-mediated EMT in lung cancer cells 靈芝蛋白(Ling Zhi-8)抑制肺癌細胞中表皮生長因子受器調控之上皮-間質轉化過程 Tung-Yi Lin 林東毅 碩士 國立陽明大學 醫學生物技術暨檢驗學系 100 Ling Zhi-8 (LZ-8) is a human immune-modulatory protein from Ganoderma lucidum. Our recent study demonstrated that LZ-8 effectively can prevent lung cancer cell proliferation; however, the mechanism of recombinant LZ-8 (rLZ-8) exhibits anti-metastasis property is unclear. Epithelial-mesenchymal transition (EMT) process has been regarded as the critical event in tumor metastasis and induced by multi-signaling pathway. The epidermal growth factor receptor (EGFR)-mediated signal transductions play an important role in tumor progression and EMT process. Regulation of Snail, through EGF-induced downstream signaling activation, plays a pivotal role of EMT determinate. We hypothesized that rLZ-8 may suppress the EGFR-driven EMT in human non small cell lung cancer cells (NSCLC). Treatment of lung cancer cells with rLZ-8 induced E-cadherin and inhibited N-cadherin as well as it significantly inhibits EGFR-induced cell motility in vitro. The mechanism of rLZ-8 mediated inhibition of EMT was corroborated by suppressing autophosphorylation of FAK and reduces Src activity. Concomitantly, rLZ-8 also suppresses ERK and AKT downstream pathways and Snail expression. It was further demonstrated that rLZ-8 suppresses tumor growth and metastasis in Lewis lung carcinoma cells-bearing mice. Interesting, rLZ-8 significantly and specifically downregulates EGFR protein level in vitro and in vivo. In conclusion, the role of rLZ-8 in the regulation of EMT was inhibited by downregulation of EGFR level and by suppression of FAK activity. These findings suggest that rLZ-8 may be a potentially anti-metastasis agent in the treatment of human NSCLC. Hsien-Yeh Hsu 許先業 2012 學位論文 ; thesis 59 en_US |
collection |
NDLTD |
language |
en_US |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立陽明大學 === 醫學生物技術暨檢驗學系 === 100 === Ling Zhi-8 (LZ-8) is a human immune-modulatory protein from Ganoderma lucidum. Our recent study demonstrated that LZ-8 effectively can prevent lung cancer cell proliferation; however, the mechanism of recombinant LZ-8 (rLZ-8) exhibits anti-metastasis property is unclear. Epithelial-mesenchymal transition (EMT) process has been regarded as the critical event in tumor metastasis and induced by multi-signaling pathway. The epidermal growth factor receptor (EGFR)-mediated signal transductions play an important role in tumor progression and EMT process. Regulation of Snail, through EGF-induced downstream signaling activation, plays a pivotal role of EMT determinate. We hypothesized that rLZ-8 may suppress the EGFR-driven EMT in human non small cell lung cancer cells (NSCLC). Treatment of lung cancer cells with rLZ-8 induced E-cadherin and inhibited N-cadherin as well as it significantly inhibits EGFR-induced cell motility in vitro. The mechanism of rLZ-8 mediated inhibition of EMT was corroborated by suppressing autophosphorylation of FAK and reduces Src activity. Concomitantly, rLZ-8 also suppresses ERK and AKT downstream pathways and Snail expression. It was further demonstrated that rLZ-8 suppresses tumor growth and metastasis in Lewis lung carcinoma cells-bearing mice. Interesting, rLZ-8 significantly and specifically downregulates EGFR protein level in vitro and in vivo. In conclusion, the role of rLZ-8 in the regulation of EMT was inhibited by downregulation of EGFR level and by suppression of FAK activity. These findings suggest that rLZ-8 may be a potentially anti-metastasis agent in the treatment of human NSCLC.
|
author2 |
Hsien-Yeh Hsu |
author_facet |
Hsien-Yeh Hsu Tung-Yi Lin 林東毅 |
author |
Tung-Yi Lin 林東毅 |
spellingShingle |
Tung-Yi Lin 林東毅 Ling Zhi-8 inhibits EGFR signaling pathways-mediated EMT in lung cancer cells |
author_sort |
Tung-Yi Lin |
title |
Ling Zhi-8 inhibits EGFR signaling pathways-mediated EMT in lung cancer cells |
title_short |
Ling Zhi-8 inhibits EGFR signaling pathways-mediated EMT in lung cancer cells |
title_full |
Ling Zhi-8 inhibits EGFR signaling pathways-mediated EMT in lung cancer cells |
title_fullStr |
Ling Zhi-8 inhibits EGFR signaling pathways-mediated EMT in lung cancer cells |
title_full_unstemmed |
Ling Zhi-8 inhibits EGFR signaling pathways-mediated EMT in lung cancer cells |
title_sort |
ling zhi-8 inhibits egfr signaling pathways-mediated emt in lung cancer cells |
publishDate |
2012 |
url |
http://ndltd.ncl.edu.tw/handle/59224975227450337450 |
work_keys_str_mv |
AT tungyilin lingzhi8inhibitsegfrsignalingpathwaysmediatedemtinlungcancercells AT líndōngyì lingzhi8inhibitsegfrsignalingpathwaysmediatedemtinlungcancercells AT tungyilin língzhīdànbáilingzhi8yìzhìfèiáixìbāozhōngbiǎopíshēngzhǎngyīnzishòuqìdiàokòngzhīshàngpíjiānzhìzhuǎnhuàguòchéng AT líndōngyì língzhīdànbáilingzhi8yìzhìfèiáixìbāozhōngbiǎopíshēngzhǎngyīnzishòuqìdiàokòngzhīshàngpíjiānzhìzhuǎnhuàguòchéng |
_version_ |
1718062170922549248 |